Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report.

Joshua MacAusland-BergAmy WiebeRadhika MarwahKatelyn C Halpape

Published in: Canadian journal of pain = Revue canadienne de la douleur (2022)

This case provides an example of the potential benefit buprenorphine/naloxone can have for patients with chronic pain and previous opioid exposure, especially older adults at risk of central adverse effects of opioids.

Keyphrases

chronic pain
low dose
pain management
physical activity
case report
high dose
middle aged
risk assessment